- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 941465, 8 pages
VEGF Is Involved in the Increase of Dermal Microvascular Permeability Induced by Tryptase
1Department of Physiology and Pathophysiology, Fudan University Shanghai Medical College, Shanghai 200032, China
2Department of Cardiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200032, China
Received 5 February 2012; Accepted 13 March 2012
Academic Editors: E. Pasmatzi and A. Zalewska
Copyright © 2012 Qianming Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. J. Galli and M. Tsai, “Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity,” European Journal of Immunology, vol. 40, no. 7, pp. 1843–1851, 2010.
- E. Garbuzenko, A. Nagler, D. Pickholtz et al., “Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis,” Clinical and Experimental Allergy, vol. 32, no. 2, pp. 237–246, 2002.
- D. A. Groneberg, F. Serowka, N. Peckenschneider et al., “Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1,” Journal of Neuroimmunology, vol. 161, no. 1-2, pp. 87–92, 2005.
- T. C. Theoharides and D. E. Cochrane, “Critical role of mast cells in inflammatory diseases and the effect of acute stress,” Journal of Neuroimmunology, vol. 146, no. 1-2, pp. 1–12, 2004.
- J. Kalesnikoff and S. J. Galli, “New developments in mast cell biology,” Nature Immunology, vol. 9, no. 11, pp. 1215–1223, 2008.
- M. Metz, M. A. Grimbaldeston, S. Nakae, A. M. Piliponsky, M. Tsai, and S. J. Galli, “Mast cells in the promotion and limitation of chronic inflammation,” Immunological Reviews, vol. 217, no. 1, pp. 304–328, 2007.
- K. Norrby, “Mast cells and angiogenesis: review article,” APMIS, vol. 110, no. 5, pp. 355–371, 2002.
- L. B. Schwartz, K. Sakai, T. R. Bradford et al., “The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis,” Journal of Clinical Investigation, vol. 96, no. 6, pp. 2702–2710, 1995.
- S. Jogie-Brahim, H. K. Min, Y. Fukuoka, H. Z. Xia, and L. B. Schwartz, “Expression of alpha-tryptase and beta-tryptase by human basophils,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1086–1092, 2004.
- Y. Fukuoka and L. B. Schwartz, “Human β-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors,” Biochemistry, vol. 43, no. 33, pp. 10757–10764, 2004.
- Y. Fukuoka and L. B. Schwartz, “The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized β-tryptase to form monomers that are inactive at neutral pH and active at acidic pH,” Journal of Immunology, vol. 176, no. 5, pp. 3165–3172, 2006.
- G. Bazzoni and E. Dejana, “Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis,” Physiological Reviews, vol. 84, no. 3, pp. 869–901, 2004.
- O. E. Kolokitha and E. Chatzistavrou, “Allergic reactions to nickel-containing orthodontic appliances: clinical signs and treatment alternatives,” World Journal of Orthodontics, vol. 9, no. 4, pp. 399–406, 2008.
- T. Imamura, A. Dubin, W. Moore, R. Tanaka, and J. Travis, “Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens,” Laboratory Investigation, vol. 74, no. 5, pp. 861–870, 1996.
- C. Jacob, P. C. Yang, D. Darmoul et al., “Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and β-arrestins,” Journal of Biological Chemistry, vol. 280, no. 36, pp. 31936–31948, 2005.
- M. Lytinas, D. Kempuraj, M. Huang et al., “Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine,” Allergy and Asthma Proceedings, vol. 23, no. 1, pp. 45–51, 2002.
- Y. Itoh, T. Sendo, and R. Oishi, “Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function,” Journal of Pharmacological Sciences, vol. 97, no. 1, pp. 14–19, 2005.
- T. Murohara, J. R. Horowitz, M. Silver et al., “Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin,” Circulation, vol. 97, no. 1, pp. 99–107, 1998.
- D. O. Bates and S. J. Harper, “Regulation of vascular permeability by vascular endothelial growth factors,” Vascular Pharmacology, vol. 39, no. 4-5, pp. 225–237, 2002.
- D. Feng, J. A. Nagy, R. A. Brekken et al., “Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF- expressing tumors and adenoviral vectors,” Journal of Histochemistry and Cytochemistry, vol. 48, no. 4, pp. 545–556, 2000.
- L. F. Brown, S. M. Olbricht, B. Berse et al., “Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions,” Journal of Immunology, vol. 154, no. 6, pp. 2801–2807, 1995.
- Y. Zhang, H. Matsuo, and E. Morita, “Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis,” Archives of Dermatological Research, vol. 297, no. 9, pp. 425–429, 2006.
- P. M. Davison, K. Bensch, and M. A. Karasek, “Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture,” Journal of Investigative Dermatology, vol. 75, no. 4, pp. 316–321, 1980.
- P. M. Davison and M. A. Karasek, “Human dermal microvascular endothelial cells in vitro: effect of cyclic AMP on cellular morphology and proliferation rate,” Journal of Cellular Physiology, vol. 106, no. 2, pp. 253–258, 1981.
- R. M. Marks, M. Czerniecki, and R. Penny, “Human dermal microvascular endothelial cells: an improved method for tissue culture and a description of some singular properties in culture,” In Vitro Cellular & Developmental Biology, vol. 21, no. 11, pp. 627–635, 1985.
- K. Gupta, S. Ramakrishnan, P. V. Browne, A. Solovey, and R. P. Hebbel, “A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor,” Experimental Cell Research, vol. 230, no. 2, pp. 244–251, 1997.
- V. V. Orlova, M. Economopoulou, F. Lupu, S. Santoso, and T. Chavakis, “Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts,” Journal of Experimental Medicine, vol. 203, no. 12, pp. 2703–2714, 2006.
- Q. Bai, L. Xu, G. Kakiyama et al., “Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells,” Atherosclerosis, vol. 214, no. 2, pp. 350–356, 2011.
- X. P. Yang, Y. Li, Y. Wang, Y. Wang, and P. Wang, “β-Tryptase up-regulates vascular endothelial growth factor expression via proteinase-activated receptor-2 and mitogen-activated protein kinase pathways in bone marrow stromal cells in acute myeloid leukemia,” Leukemia & Lymphoma, vol. 51, no. 8, pp. 1550–1558, 2010.
- C. P. Sommerhoff, W. Bode, G. Matschiner, A. Bergner, and H. Fritz, “The human mast cell tryptase tetramer: a fascinating riddle solved by structure,” Biochimica et Biophysica Acta, vol. 1477, no. 1-2, pp. 75–89, 2000.
- S. Ren, A. E. Lawson, M. Carr, C. M. Baumgarten, and L. B. Schwartz, “Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12,” Journal of Immunology, vol. 159, no. 7, pp. 3540–3548, 1997.
- L. B. Schwartz, “Tryptase: a mast cell serine protease,” Methods in Enzymology, vol. 244, pp. 88–100, 1994.
- R. J. Blair, H. Meng, M. J. Marchese et al., “Human mast cells stimulate vascular tube formation. tryptase is a novel, potent angiogenic factor,” Journal of Clinical Investigation, vol. 99, no. 11, pp. 2691–2700, 1997.
- D. D. Metcalfe, D. Baram, and Y. A. Mekori, “Mast cells,” Physiological Reviews, vol. 77, no. 4, pp. 1033–1079, 1997.
- H. F. Dvorak, L. F. Brown, M. Detmar, and A. M. Dvorak, “Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis,” The American Journal of Pathology, vol. 146, no. 5, pp. 1029–1039, 1995.
- Y. C. Lee, Y. G. Kwak, and C. H. Song, “Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma,” Journal of Immunology, vol. 168, no. 7, pp. 3595–3600, 2002.
- C. G. Lee, H. Link, P. Baluk et al., “Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung,” Nature Medicine, vol. 10, no. 10, pp. 1095–1103, 2004.
- K. S. Lee, S. R. Kim, H. S. Park, G. Y. Jin, and Y. C. Lee, “Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression,” Journal of Allergy and Clinical Immunology, vol. 114, no. 5, pp. 1093–1099, 2004.
- H. F. Dvorak, “Discovery of vascular permeability factor (VPF),” Experimental Cell Research, vol. 312, no. 5, pp. 522–526, 2006.
- D. Ribatti, “The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review,” British Journal of Haematology, vol. 128, no. 3, pp. 303–309, 2005.